(Q51024315)

27 March 2018

title

DNA ploidy and p53 expression correlate with survival and cell proliferative activity in male breast carcinoma. (English)

1 reference

27 March 2018

author name string

A Pich

1

1 reference

27 March 2018

E Margaria

2

1 reference

27 March 2018

L Chiusa

3

1 reference

27 March 2018

R Ponti

4

1 reference

27 March 2018

M Geuna

5

1 reference

27 March 2018

language of work or name

English

0 references

publication date

1 July 1996

1 reference

27 March 2018

published in

Human Pathology

1 reference

27 March 2018

volume

27

1 reference

27 March 2018

issue

7

1 reference

27 March 2018

page(s)

676-682

1 reference

27 March 2018

Carcinoma of the male breast

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

Male breast carcinoma--a review of 301 cases from the Christie Hospital & Holt Radium Institute, Manchester

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

Prognosis of breast cancer in males: an analysis of 170 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

Immunocytochemical estrogen and progestin receptor assays in breast cancer with monoclonal antibodies. Histopathologic, demographic, and biochemical correlations and relationship to endocrine response and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

Expression of cathepsin D and estrogen receptor in male breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

Tumour DNA ploidy as an independent prognostic factor in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

Node negative breast cancer: The prognostic value of DNA ploidy for long-term survival

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

DNA index, S-phase fraction, histological grade and prognosis in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

Lack of prognostic significance of DNA ploidy and S phase fraction in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

DNA ploidy and the percentage of cells in S-phase as prognostic factors for women with lymph node negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

Flow cytometric (DNA content and S-phase fraction) analysis of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

Prognostic significance of DNA ploidy in male breast carcinoma. A retrospective analysis of 32 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

DNA content and S-phase fraction in male breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

Mutations in the p53 gene occur in diverse human tumour types

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

The p53 tumour suppressor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

p53 overexpression in formalin-fixed, paraffin-embedded tissue detected by immunohistochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast Cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

Immunohistochemical detection of p53 protein in mammary carcinoma: an important new independent indicator of prognosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

p53 protein expression in breast cancer as related to histopathological characteristics and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

Expression of p53 protein in benign epithelial hyperplasia, atypical ductal hyperplasia, non-invasive and invasive mammary carcinoma: an immunohistochemical study.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

Prognostic significance of TP53 alterations in breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

p53 as an independent prognostic marker in lymph node-negative breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

Mutations of the p53 gene in male breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

Identity of the proliferating cell nuclear antigen and cyclin

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

Proliferating-cell nuclear antigen (PC10) immunolabelling and other proliferation indices as prognostic factors in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

Comparison of nuclear DNA content in primary and metastatic differentiated thyroid carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

Argyrophilic nucleolar organiser region counts and prognosis in pharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

Immunohistochemistry of estrogen receptor protein in paraffin sections. Effects of enzymatic pretreatment and cobalt chloride intensification

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

DNA flow cytometric analysis of primary operable breast cancer. Relation of ploidy and S-phase fraction to outcome of patients in NSABP B-04.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

Flow cytometric determination of breast tumor heterogeneity

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

Flow cytometric measurements of DNA and other cell components in human tumors: a critical appraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

Argyrophilic nucleolar organizer regions in breast carcinoma. Correlation with dna flow cytometry, histopathology, and lymph node status

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

Nucleolar organizer regions related to morphometry, flow cytometry, sex steroid receptor content, tumour histology and prognosis in female breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

Assessment of nucleolar organizer regions by automatic image analysis in breast cancer: correlation with DNA content, proliferation rate, receptor status and histopathological grading

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

Nucleolar organiser regions (AgNORs) as predictors in transitional cell bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

Long-term survival of thymoma patients by histologic pattern and proliferative activity

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

Retinoblastoma and p53 gene product expression in breast carcinoma: immunohistochemical analysis and clinicopathologic correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

Expression of p53 protein in infiltrating and in-situ breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

Variations in immunohistochemical detection of p53 protein overexpression in cervical carcinomas with different antibodies and methods of detection

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

p53 accumulation in ovarian carcinomas and its prognostic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

Expression of proliferating cell nuclear antigen (PC10), p53 protein and c-erbB-2 in renal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

p53 tumor suppressor oncogene expression in squamous cell carcinoma of the hypopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

p53 in tumour pathology: can we trust immunohistochemistry?--Revisited!

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

P53 expression in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

Comparative immunohistochemical studies of p53 and proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions in pancreatic duct cell carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2896%2990397-4

7 January 2021

10.1016/S0046-8177(96)90397-4

Identifiers

DOI

1 reference

27 March 2018

1 reference

27 March 2018